Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Filings indexed 649 across all filing types
Latest filing 2026-02-24 Regulatory Filings
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Sprawozdanie z działalności za 2025 -podpis
Regulatory Filings
2026-02-24 Polish
Sprawozdanie z działalności za 2025
Regulatory Filings
2026-02-24 Polish
Jednostkowe sprawozdanie finansowe za 2025 - podpis
Regulatory Filings
2026-02-24 Polish
Jednostkowe sprawozdanie finansowe za 2025
Regulatory Filings
2026-02-24 Polish
Wybrane dane finansowe za 2025 -podpis
Regulatory Filings
2026-02-24 Polish
Wybrane dane finansowe za 2025
Regulatory Filings
2026-02-24 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.